Phase 3 Readout~month

Phase 3 Topline: A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema

Drug
orally
Indication
Hereditary Angioedema; Hereditary Angioedema (HAE); Hereditary Angioedema Type I

Other upcoming events for PHVS

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and S
Phase 3 ReadoutPhase 3 Topline: A Long-term, Open-label Study to Evaluate the Safety and Efficacy of Orally Administered Deucrictiba

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema — PHVS Phase 3 Readout | BioSniper